Harry Kotlarz

Harry Kotlarz brings more than two decades of leading health economics and market access functions to his role. He has a diverse background and experience representing start-up, established medical device companies including Medtronic and Johnson and Johnson as well as experience in Health Technology Assessment from his time at ECRI. His blend of industry experience, multiple stakeholder engagement, and evidence-based solutions has contributed to coverage and access for innovative technologies helping more patients. He has been responsible for the evidence required for value-based healthcare, reimbursement, and health policy-related issues including quality, new payment models, comparative effectiveness, and cost-effectiveness outcomes. He has collaborated closely with external stakeholders on how to deliver value and better patient outcomes in these new models of healthcare delivery. Harry obtained his MBA from Xavier University and BS from Thompson Rivers University.